Dr. Da-Yong LU was born in July 1962 in Shanghai. oc/professor; ed/Ph.D. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 2005, MS, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 1986, BS, Shanghai Medical University (Now Fudan University-affiliated) in1982; He is working as an associated professor at Shanghai University, Shanghai200444, PR China. Undergo the studies of cancer pathology, biochemistry, pharmacology, and clinical therapeutics, especially on the pharmacological studies of new Chinese anticancer agent probimane and MST-16 and antimetastatic targets of fibrinogen and sialic acids and individualized cancer chemotherapy (ICC) since 1982. His interest is focused on the basic studies of cancer biology, pathology, treatment, origins of life, and other fields of science disciplines. He is serving as an editorial member of several reputed international journals. He was the first author of more than 100 original scientific articles and five books on cancer therapeutics, suicide risks/therapeutics, HIV/AIDS studies, drug developments, nursery, and others.

Dr. Da-Yong LU is interested in the experimental study and clinical practice in a number of human diseases.